SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-013493
Filing Date
2023-02-27
Accepted
2023-02-27 21:33:19
Documents
1
Period of Report
2023-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13960
  Complete submission text file 0001209191-23-013493.txt   15345
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ENLIVEN THERAPEUTICS INC 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Kintz Samuel (Reporting) CIK: 0001967168 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 23678051